Sri Lanka study finds Sinopharm jab highly efficient
2021-07-22 00:00
Researchers in Sri Lanka have found the Chinadeveloped Sinopharm COVID vaccine to be highly efficient against the Delta variant that is driving a resurgence in infections around the world. The antibody responses to the Delta variant and neutralizing antibodies were similar to levels seen following natural infection, the researchers from Colombos Sri Jayewardenepura University said on its website on Monday. According to the study,  percent of those who received two doses of the Sinopharm vaccine developed antibodies against SARSCoV, the virus that causes COVID.                                                                                                                                                                                                                                                                           !CDATA            function shareweixin              var ua  navigator.userAgent.toLowerCase              ifiphoneipadipod.testua  ua.matchMicroMessengeri  micromessenger                window.opena.app.qq.comosimple.jsp?pkgnamecom.theotino.chinadailyiosschemeencodeIos                            else ifandroid.testua  ua.matchMicroMessengeri  micromessenger                window.opena.app.qq.comosimple.jsp?pkgnamecom.theotino.chinadailyandroidschemeencodeAndroid                            else                window.openwww.chinadaily.com.cnmobiledaily.html